Form 4 Filing for CG Oncology, Inc. - Officer/Director Transaction

This filing details transactions made by James Mulay, a director at CG Oncology, Inc. (CGON). On April 17, 2026, Mulay exercised vested stock options for 15,600 shares of Common Stock at a conversion price of $36.63 per share. Simultaneously, he disposed of 15,600 shares of Common Stock at a weighted average price of $73.01, with prices ranging from $72.99 to $73.04. These sales were conducted under a Rule 10b5-1 trading plan. Following these transactions, Mulay has 0 shares of Common Stock directly held and 0 vested options remaining.